Skip to main content

International Psoriasis Council

Advancing Knowledge. Improving Care.

Robert E. Kalb Headshot

Robert

Kalb

,

MD

Clinical Professor
SUNY at Buffalo School of Medicine
Buffalo
,
New York
,
United States
Councilor Since: March 1, 2017
IPC Councilor
Dr. Robert E. Kalb is a Clinical Professor of Dermatology at the State University of New York at Buffalo School of Medicine and Biomedical Sciences (SUNY Buffalo) and an Adjunct Professor of Dermatology at the Perelman School of Medicine at the University of Pennsylvania. He received his medical degree cum laude from SUNY Downstate Health Sciences University in 1982. He completed his dermatology training at Columbia University’s College of Physicians and Surgeons, where he served as Chief Resident in his final year.

Dr. Kalb has extensive experience managing psoriasis, atopic dermatitis, and other inflammatory skin diseases. He has authored 70+ publications and is actively involved in clinical research, particularly focused on new therapeutic options for psoriasis. A frequent lecturer at national and international dermatology meetings, he plays a significant role in medical education, mentoring both medical students and dermatology residents.

Since 1989, Dr. Kalb has been in private practice with the Buffalo Medical Group, where he also oversees the Phototherapy Department, one of the leading centers for psoriasis care in Western New York. He is Board Certified by the American Board of Dermatology and is a member of the American Academy of Dermatology (AAD).
Last Updated:
07/10/2025

Areas of Interest

Treating patients. I have a large clinical psoriasis practice, teaching of residents and medical students, participating in phase 3 clinical trials.

Languages Spoken

English

Involvement with Other Organization(s)

Serves on the National Psoriasis Foundation (NPF) medical board.

What's New

Videos Now Available from the IPC Symposium at SID Chicago

Did you miss the IPC symposium at the 83rd Society for Investigative Dermatology (SID) Annual Meeting? Select session videos are now available. The Arc of Disease Control in Psoriasis: Early Interception – Deep Pathway Blockade – Treatment Failure covered early intervention strategies, treatment selection, immune pathway targeting, PsA prevention, clinical escape, and real-world cases that inform long-term psoriasis care.

WATCH NOW

Wednesday, June 17, 2026

Take Ten: Mio Nakamura – Psoriasis and Mental Health

Depression affects approximately 20% of patients with psoriasis, five times the rate seen in the general population. IPC Jr. Councilor Mio Nakamura, MD, MS, FAAD, walks through the bidirectional relationship between psoriasis and depression, the shared inflammatory pathways driving both conditions, and practical guidance on screening and incorporating multidisciplinary mental health support into psoriasis management.

WATCH NOW

Thursday, June 11, 2026